We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$6.57B
AUM Growth
+$83.2M
Cap. Flow
+$171M
Cap. Flow %
2.61%
Top 10 Hldgs %
34.7%
Holding
396
New
51
Increased
77
Reduced
121
Closed
60

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$120M
2
AMAT icon
Applied Materials
AMAT
+$102M
3
JPM icon
JPMorgan Chase
JPM
+$91.6M
4
PHG icon
Philips
PHG
+$84.9M
5
PF
Pinnacle Foods, Inc.
PF
+$72.7M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$131M
2
MRK icon
Merck
MRK
+$126M
3
CMCSA icon
Comcast
CMCSA
+$104M
4
QCOM icon
Qualcomm
QCOM
+$77.7M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$60.4M

Sector Composition

Rank Sector Weight
1 Healthcare 17.53%
2 Financials 16.08%
3 Technology 13.74%
4 Industrials 10.72%
5 Energy 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$144B
$298M 4.53%
10,618,655
+499,716
+5% +$14M
GE icon
2
GE Aerospace
GE
$366B
$258M 3.92%
2,097,714
+178,735
+9% +$22.3M
C icon
3
Citigroup
C
$215B
$234M 3.57%
4,523,485
-226,116
-5% -$11.4M
ETN icon
4
Eaton
ETN
$140B
$232M 3.53%
3,663,148
+577,808
+19% +$41M
OXY icon
5
Occidental Petroleum
OXY
$55.7B
$229M 3.49%
2,486,814
+564,466
+29% +$54.2M
CVA
6
DELISTED
Covanta Holding Corporation
CVA
$225M 3.42%
10,591,409
+1,902,577
+22% +$39.7M
JPM icon
7
JPMorgan Chase
JPM
$928B
$216M 3.28%
3,577,844
+1,567,501
+78% +$91.6M
PF
8
DELISTED
Pinnacle Foods, Inc.
PF
$213M 3.23%
6,509,408
+2,297,920
+55% +$72.7M
EMC
9
DELISTED
EMC CORPORATION
EMC
$194M 2.95%
6,618,170
+455,580
+7% +$13.1M
AAPL icon
10
Apple
AAPL
$5.01T
$182M 2.77%
7,234,164
-580,128
-7% -$14.2M
ALL icon
11
Allstate
ALL
$71B
$182M 2.77%
2,960,522
+245,835
+9% +$14.8M
MDT icon
12
Medtronic
MDT
$113B
$147M 2.24%
2,375,616
+602,982
+34% +$38.3M
AGN
13
DELISTED
Allergan plc
AGN
$133M 2.02%
551,388
+537,111
+3,762% +$120M
BIO icon
14
Bio-Rad Laboratories Class A
BIO
$8.79B
$117M 1.78%
1,032,881
+79,080
+8% +$9.37M
CB icon
15
Chubb
CB
$141B
$110M 1.67%
1,046,170
+232,102
+29% +$24.2M
ORCL icon
16
Oracle
ORCL
$341B
$107M 1.63%
2,794,938
-9,733
-0.3% -$394K
GM icon
17
General Motors
GM
$81.3B
$107M 1.63%
3,347,953
+404,985
+14% +$14.1M
PHG icon
18
Philips
PHG
$25.3B
$103M 1.58%
4,709,136
+3,955,341
+525% +$84.9M
AMAT icon
19
Applied Materials
AMAT
$353B
$99.5M 1.52%
+4,606,467
New +$102M
WMB icon
20
Williams Companies
WMB
$85.8B
$93.6M 1.43%
1,691,815
-43,658
-3% -$2.51M
HOLX
21
DELISTED
Hologic
HOLX
$90.5M 1.38%
3,721,398
-1,034,001
-22% -$26.1M
XLS
22
DELISTED
EXELIS INC COM STK
XLS
$87M 1.32%
5,258,307
+2,961,033
+129% +$48.1M
VZ icon
23
Verizon
VZ
$201B
$85.2M 1.3%
1,704,914
+36,075
+2% +$1.79M
MET icon
24
MetLife
MET
$62.6B
$79.3M 1.21%
1,656,821
+95,116
+6% +$4.62M
JNJ icon
25
Johnson & Johnson
JNJ
$644B
$76.4M 1.16%
716,646
-49,095
-6% -$5.09M
1
2 3 4 5

Similar funds

MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
MCM
Mill Capital Management Concord, North Carolina $1.31B AUM 17.4% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Levin Capital Strategies's Q3 2014 Portfolio in Review

As of Q3 2014, Levin Capital Strategies held 396 positions worth $6.57B, up 1.3% from $6.49B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Levin Capital Strategies's Q3 2014 filing shows 51 new, 77 increased, 121 reduced and 60 closed positions. Its largest new stake was Applied Materials: 4,606,467 shares worth $99.5M. The largest sale was Wells Fargo, an estimated $131M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Levin Capital Strategies's largest Q3 2014 buy was Applied Materials: 4,606,467 shares worth $99.5M.
  • Levin Capital Strategies added most to Allergan plc in Q3 2014, an estimated $120M increase.
  • Levin Capital Strategies's biggest Q3 2014 reduction was Merck, cutting an estimated $126M.
  • Levin Capital Strategies fully exited Wells Fargo in Q3 2014, selling an estimated $131M.
  • Levin Capital Strategies's ten largest holdings make up 35% of its $6.57B portfolio in Q3 2014.
  • Levin Capital Strategies opened 51 new positions and closed 60 in Q3 2014.
  • Levin Capital Strategies's portfolio value rose 1.3% quarter-over-quarter to $6.57B.

Based on Levin Capital Strategies's 13F filing for Q3 2014, filed 12 Nov 2014.